Clinical Trial Update: Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ticagrelor versus clopidogrel for residual thrombus burden during PCI (OCT study) has been withdrawn. The study targeted patients with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Acute Coronary Syndrome, Coronary Artery Disease | Phase 4 | Status: WITHDRAWN